Novo Nordisk has promoted Rishang Deoras to Global Director - Diabetes Commercial Unit.Deoras shared the news in a LinkedIn ...

Michael Field, chief EMEA equity strategist at Morningstar, discusses European stocks amid tariff uncertainty. Despite a court order, White House bars AP from Oval Office event Actors Who Refused ...

Henvender sig til alle, der arbejder med energi, affaldshåndtering og vandforsyning, og som vil følge de politiske kampe og beslutninger på områderne.Henvender sig til alle, der arbejder med energi, ...

So was the case with a particular brooch Queen Camilla wore this week while in Italy with husband King Charles—a trip that also coincided with their landmark 20th wedding anniversary.

In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...

Queen Camilla's transformation from vilified mistress to highly-respected member of the Firm has been documentated in front of our eyes. With the King by her side, Camilla, 77, has expertly grown ...

Novo Nordisk (NVO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

PITTSBURGH (CN) — Bashing a Biden-era law that gives Medicare the power to directly negotiate the price of certain high-cost prescription drugs, an attorney for the pharmaceutical giant Novo Nordisk ...

Royal duties call, but King Charles III and Queen Camilla always have time for romance. The British monarch and his longtime partner, who celebrate their 20th wedding anniversary on Wednesday ...

Camilla Sylvest har tilbragt hele sin karriere i Novo Nordisk, hvor hun har arbejdet sig til tops. Hun har dog aldrig haft et mål om at havne på den øverste hylde, for hendes ambitioner har altid ...

we're raising our Lilly fair value estimate to $650 per share from $620 and maintaining our DKK 640/$89 fair value estimate for Novo Nordisk. We had not assumed this proposed rule would pass ...